ZIOP

J.P. Morgan Weighs In on ZIOPHARM Oncology Inc. Following New Collaboration with Intrexon

J.P.

Jason Cohen — September 29, 2015, 3:08 PM EDT

Company Update (NASDAQ:ZIOP): Intrexon and ZIOPHARM Oncology Inc. to Develop Immunotherapies for Treatment of Graft-Versus-Host Disease

Intrexon Corporation (NYSE:XON), a leader in synthetic biology, announced it has formed a new Exclusive Channel Collaboration (ECC) with ZIOPHARM Oncology Inc.(NASDAQ:ZIOP), a …

Corey Williams — September 28, 2015, 4:57 PM EDT

Stock Update (NASDAQ:ZIOP): ZIOPHARM Oncology Inc. Appoints Scott Tarriff to Its Board of Directors

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immunotherapies, today announced the appointment of Scott Tarriff …

Corey Williams — September 28, 2015, 8:31 AM EDT

Stock Update (NASDAQ:ZIOP): ZIOPHARM Oncology Inc. Announces Presentation of Clinical and Preclinical Data From Ad-RTS-IL-12 at CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immunotherapies, today announced the presentation of clinical …

Corey Williams — September 18, 2015, 4:59 PM EDT

Griffin Pounds the Table on ZIOPHARM Oncology Inc. (ZIOP)

Griffin’s healthcare analyst Keith Markey was out pounding the table on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), reiterating a Buy rating and price target of $21, …

Jason Cohen — September 17, 2015, 4:31 PM EDT

Stock Update (NASDAQ:ZIOP): ZIOPHARM Oncology Inc. Announces Cancer Research Publication of Study Demonstrating Preferential Targeting of Solid Tumor Cells by Modified CAR T Cells

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immuno-therapies, today announced the publication of a …

Corey Williams — September 1, 2015, 8:15 AM EDT

J.P. Morgan Reiterates Neutral on Ziopharm Oncology Inc Following 2Q Results

J.P.

Jason Cohen — August 12, 2015, 10:51 AM EDT

Monday Morning Pre-Market Insights: Advanced Micro Devices, Inc. (AMD), ZIOPHARM Oncology Inc. (ZIOP), Epizyme Inc (EPZM), Bioline RX Ltd (BLRX)

Advanced Micro Devices, Inc. (NASDAQ:AMD) increased 3.

Kate George, Editor — June 22, 2015, 8:22 AM EDT

Insider Selling Update: Walt Disney Co (DIS), Micron Technology, Inc. (MU), Palo Alto Networks Inc (PANW), ZIOPHARM Oncology Inc. (ZIOP)

Recently, various executives have taken part in insider selling activity for the stocks of Walt Disney Co (NYSE:DIS), Micron Technology, Inc. (NASDAQ:MU), Palo Alto …

Kate George, Editor — June 13, 2015, 8:06 PM EDT